Previous Close | 4.9700 |
Open | 5.0600 |
Bid | 3.6600 x 2200 |
Ask | 5.0200 x 800 |
Day's Range | 4.9000 - 5.1917 |
52 Week Range | 3.6600 - 11.8200 |
Volume | |
Avg. Volume | 352,204 |
Market Cap | 169.599M |
Beta (5Y Monthly) | -1.14 |
PE Ratio (TTM) | 3.80 |
EPS (TTM) | 1.3120 |
Earnings Date | Aug 10, 2022 - Aug 15, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 18.33 |
Subscribe to Yahoo Finance Plus to view Fair Value for CODX
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be presenting at the H.C. Wainwright & Co. 2022 Global Investment Conference, being held in-person and virtually on May 23-26 in Miami, Florida.
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today financial results for the first quarter ended March 31, 2022.
Co-Diagnostics, Inc. ( NASDAQ:CODX ) shareholders might understandably be very concerned that the share price has...